


Searching News Database: BioInvent International
HSMN NewsFeed - 16 Mar 2012
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
Additional items found! 2
Members Archive contains
2 additional stories matching:
BioInvent International
(Password required)
BioInvent International
(Password required)
